Recent News

• 03.11.2025 - Barclays 27th Annual Global Healthcare Conference
• 03.05.2025 - Innoviva to Participate in the Barclays 27th Annual Global Healthcare Conference
• 02.26.2025 - Innoviva Reports Fourth Quarter and Full Year 2024 Financial Results; Highlights Recent Company Progress
• 02.11.2025 - Oppenheimer 35th Annual Healthcare Life Sciences Conference
• 02.06.2025 - Innoviva to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
• 12.16.2024 - Innoviva Specialty Therapeutics Signs Exclusive Distribution and Licensing Agreement to Acquire U.S. Marketing Rights for Zevtera® (ceftobiprole)
• 12.05.2024 - Citi 2024 Global Healthcare Conference
• 11.26.2024 - Innoviva to Participate in the Citi 2024 Global Healthcare Conference
• 11.13.2024 - UBS Global Healthcare Conference
• 11.12.2024 - Innoviva to Participate in the UBS Global Healthcare Conference

Recent Filings

• 02.26.2025 - EX-99.1 EX-99.1
• 02.26.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.26.2025 - 8-K Current report
• 02.24.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.24.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.11.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.27.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.22.2024 - 4 Statement of changes in beneficial ownership of securities
• 11.14.2024 - SC 13D/A General Statement of Acquisition of Beneficial Ownership